JOAQUÍN MARÍA
BELZUNEGUI OTANO
Forscher bis um 2022
Hospital Universitario de Donostia
San Sebastián, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Donostia (31)
2024
-
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
RMD open, Vol. 10, Núm. 1
2023
-
Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice
Reumatologia Clinica, Vol. 19, Núm. 8, pp. 412-416
-
Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index
World Journal of Hepatology, Vol. 15, Núm. 5, pp. 699-706
-
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1319-1333
2022
-
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)
Rheumatology and Therapy
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
-
Real-World Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis Patients in Spain: Results of a Multicenter, Observational Study in Routine Clinical Practice (The ORBIT-RA Study)
Rheumatology and Therapy, Vol. 9, Núm. 2, pp. 589-608
-
Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition
Advances in Therapy, Vol. 39, Núm. 4, pp. 1490-1501
2021
-
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
Rheumatology and Therapy, Vol. 8, Núm. 3, pp. 1323-1339
-
Evaluation of the collaboration between Primary and Hospital Care in order to improve inappropriate prescription
Journal of Healthcare Quality Research, Vol. 36, Núm. 2, pp. 91-97
2020
-
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
2017
-
Categorización diagnóstica según los criterios del First International Workshop on Ocular Sarcoidosis (FIWOS) en una serie de 11 pacientes
Reumatologia Clinica
-
Desprescripción de tratamientos de larga duración con bisfosfonatos para la osteoporosis en atención primaria en el País Vasco
Gaceta Sanitaria, Vol. 31, Núm. 1, pp. 35-39
-
Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)
Clinical and Experimental Rheumatology, Vol. 35, pp. 28-34
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
2015
-
Colchicine use in isolated renal AA amyloidosis
Reumatologia Clinica, Vol. 11, Núm. 4, pp. 242-243
-
Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]
Seminars in Arthritis and Rheumatism
-
Secondary macrophage activation syndrome due to autoimmune, hematologic, infectious and oncologic diseases. Thirteen case series and review of the literature
Reumatologia Clinica, Vol. 11, Núm. 3, pp. 139-143